Friday, June 12, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 177 of 1,261
  1. US 11725005

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  2. US 11723900

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  3. US 11723635

    Devices and methods for umbilical cord processing

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  4. US 11723949

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  5. US 11723982

    Methods of treating an ocular disease or disorder

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  6. US 11723992

    Method for extraction and purification of 68GA

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  7. US 11725207

    Serpina1 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  8. US 11724987

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  9. US 11723762

    LIDAR based 3-D imaging with far-field illumination overlap

    VELODYNE LIDAR, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  10. US 11723946

    Methods for regulating transcription of multiple genes and expression of multiple targets

    China Medical University · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  11. US 11723887

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  12. US 11723923

    Methods of preparing T cells for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  13. US 11723922

    CXCR6-transduced T cells for targeted tumor therapy

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  14. US 11723903

    Treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  15. US 11723873

    Oral dosage form of ticagrelor and preparation method thereof

    Elite Pharmaceutical Solution Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  16. US 11723362

    Broad-spectrum synergistic antimicrobial compositions

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  17. US 11723864

    Antimicrobial and anti-inflammatory compositions

    The Board of Regents of the University of Texas System · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  18. US 11725054

    Anti-CD83 antibodies and use thereof

    The Regents of the University of California · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  19. US 11725060

    Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

    Aptevo Research and Development LLC · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  20. US 11725208

    Conjugated antisense compounds and their use

    Ionis Pharmaceuticals, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  21. US 11725209

    TMPRSS6 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  22. US 11725217

    Methods to enhance myocardial regeneration and/or repair

    Regents of the University of Minnesota · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  23. US 11725024

    Antibody drug conjugates

    Takeda Pharmaceutical Company Limited · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  24. US 11725043

    Ulinastatin polypeptides

    DiaMedica USA Inc. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.